Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pfizer
Pfizer
Page 5 of 37
Newsletters
Pfizer CEO Albert Bourla acknowledges the innate difficulty of defeating COVID
By
Bernhard Warner
and
Alan Murray
April 13, 2022
Finance
Pfizer’s new CFO is a former CVS Health finance chief—and will oversee more than numbers
By
Financial Writer
April 11, 2022
Health
Second COVID-19 booster shots protect against Omicron infections—but not for long, major study says
By
Tech Reporter
April 6, 2022
Newsletters
‘None of these scenarios is good for the business.’ Inside Ikea’s decision to withdraw from Russia
By
Bernhard Warner
and
Alan Murray
April 6, 2022
Newsletters
The 5 forces that will transform business over the next decade
By
Bernhard Warner
and
Alan Murray
April 4, 2022
Newsletters
Is it time to rethink CEO pay for companies receiving billions in state aid and subsidies?
By
Bernhard Warner
and
Alan Murray
April 1, 2022
Success
How Moderna kept its mostly millennial staff from burning out while developing the COVID vaccine
By
Blockchain Reporter
March 31, 2022
Health
Omicron has all but wiped out the more deadly Delta strain—but that’s not necessarily a good thing
By
Research Team
March 31, 2022
Newsletters
Business leaders challenge fellow CEOs to raise their game on net-zero commitments
By
Bernhard Warner
and
Alan Murray
March 31, 2022
Health
FDA approves additional Pfizer and Moderna COVID boosters for adults 50 and older
By
Lauran Neergaard
,
Matthew Perrone
and
The Associated Press
March 29, 2022
Newsletters
The pandemic has accelerated innovation across industries—particularly in health care
By
Bernhard Warner
and
Alan Murray
March 28, 2022
Health
Pfizer shares slide after it recalls blood pressure drug over cancer-risk fears
By
News Correspondent
March 23, 2022
Health
The weird case of Novavax’s falling stock price: The vaccine that might be big news for the vax hesitant
By
Market Analyst
March 15, 2022
Health
China just locked down 50 million people amid ‘stealth Omicron’ fears. The former FDA head predicts what happens next
By
Crypto Correspondent
March 15, 2022
International
Pfizer pauses clinical trials in Russia, says it will continue to send drugs to patients
By
Riley Griffin
and
Bloomberg
March 14, 2022
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Trading Desk
Economy
The analyst who once predicted the 'end of capitalism' sees Zohran Mamdani as a 'day of reckoning coming in'—and...
By
Staff Writer
Politics
Trump's FAA punishes most of nation's air traffic workers by only giving $10,000 bonuses to the 776 with perfect...
By
Josh Funk
and
The Associated Press